B oth men and women with psoriasis are equally at risk for developing psoriatic arthritis (PsA)-a chronic inflammatory ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...

Patients with psoriatic arthritis with a family history of psoriatic disease are diagnosed with psoriasis and psoriatic ...

Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce ...

The results of the Severe Psoriatic arthritis – Early intervEntion to control Disease ... suspect arthralgia and subclinical joint inflammation identified by MRI of the hands or feet. It included both ...

Learn about the symptoms and causes of juvenile arthritis, how it's diagnosed, and treatment options available for different forms of childhood arthritis.

Inflammatory arthritis is a chronic disease that can be painful and debilitating. An early diagnosis is the key to getting long-term relief.